SCHEMBL5597482

SCHEMBL5597482

COC(=O)C(C(=O)O)=C(C)c1ccc(O)c(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.59
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
SLC22A6 Q4U2R8 1/20 0.57
SLC22A8 Q8TCC7 1/20 0.57
RAB9A P51151 1/20 0.57
HSD17B2 P37059 1/20 0.49
BLM P54132 2/20 0.48
CYP1A2 P05177 1/20 0.48
HSP90AA1 P07900 1/20 0.48
HSP90AB1 P08238 1/20 0.48
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
GAA P10253 3/20 0.45
PTPN7 P35236 1/20 0.44
DUSP3 P51452 1/20 0.44
ALDH1A1 P00352 2/20 0.44
NFKB1 P19838 2/20 0.44
TSHR P16473 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597481 1.00 HTT (0.59) HTTMEN1KMT2ASLC22A6SLC22A8
Apocynin SCHEMBL28537029 0.78 HTT (0.71) HTTMEN1KMT2ASLC22A6SLC22A8
SCHEMBL8965219 0.77 MEN1 (0.62) HTTMEN1KMT2ASLC22A6SLC22A8
SCHEMBL8965222 0.77 MEN1 (0.62) HTTMEN1KMT2ASLC22A6SLC22A8
SCHEMBL30869298 0.77 MEN1 (0.62) HTTMEN1KMT2ASLC22A6SLC22A8
SCHEMBL417161 0.76 CA1 (0.53) RAB9ACYP1A2KDM4EGAAALDH1A1
SCHEMBL30921173 0.76 MEN1 (0.82) HTTMEN1KMT2ASLC22A6SLC22A8
Apocynin SCHEMBL108512 0.76 HTT (0.73) HTTMEN1KMT2ASLC22A6SLC22A8
SCHEMBL760262 0.76 MEN1 (0.82) HTTMEN1KMT2ASLC22A6SLC22A8
Apocynin SCHEMBL109372 0.76 HTT (0.73) HTTMEN1KMT2ASLC22A6SLC22A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007502314-A 2007-02-08 JP claimed
US-20070010579-A1 Copper salts of organic acids and use thereof as fungicides ISARGO S.P.A. (IT) 2007-01-11 US claimed
EP-1633190-A1 COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES ISAGRO S.p.A. (IT) 2006-03-15 EP claimed
WO-2004103074-A1 COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES ISAGRO S.P.A. (IT) 2004-12-02 WO claimed
US-20070010579-A1 Copper salts of organic acids and use thereof as fungicides ISARGO S.P.A. (IT) 2007-01-11 US disclosed
EP-1633190-A1 COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES ISAGRO S.p.A. (IT) 2006-03-15 EP disclosed
WO-2004103074-A1 COPPER SALTS OF ORGANIC ACIDS AND USE THEREOF AS FUNGICIDES ISAGRO S.P.A. (IT) 2004-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010579-A1 Copper salts of organic acids and use thereof as fungicides AOC3, AOC2, AOC1 HTT 3294/4885MEN1 469/4885KMT2A 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.